| JPM THEMATICS-GENETIC THERAPIES C (DIST) USD | RVI BIOTECNOLOGÍA | 66,640420 | 10/07/2026 | 17,03% | 20,42% | ** |
| JPM THEMATICS-GENETIC THERAPIES I (ACC) EUR | RVI BIOTECNOLOGÍA | 82,540000 | 10/07/2026 | 16,95% | 21,88% | ** |
| ABANTE GLOBAL FUNDS - ABANTE LIFE SCIENCES FUND A USD CAP | RVI BIOTECNOLOGÍA | 9,609095 | 09/07/2026 | 16,88% | 52,22% | *** |
| ABANTE GLOBAL FUNDS - ABANTE LIFE SCIENCES FUND C USD CAP | RVI BIOTECNOLOGÍA | 9,627460 | 09/07/2026 | 16,87% | 52,23% | *** |
| ABANTE GLOBAL FUNDS - ABANTE LIFE SCIENCES FUND C EUR CAP | RVI BIOTECNOLOGÍA | 11,792000 | 09/07/2026 | 16,85% | 52,53% | *** |
| ABANTE GLOBAL FUNDS - ABANTE LIFE SCIENCES FUND A EUR CAP | RVI BIOTECNOLOGÍA | 13,924000 | 09/07/2026 | 16,84% | 52,52% | *** |
| JPM THEMATICS-GENETIC THERAPIES A (ACC) USD | RVI BIOTECNOLOGÍA | 111,391076 | 10/07/2026 | 16,78% | 20,04% | ** |
| JPM THEMATICS-GENETIC THERAPIES A (DIST) USD | RVI BIOTECNOLOGÍA | 110,839895 | 10/07/2026 | 16,75% | 19,78% | ** |
| ABANTE GLOBAL FUNDS - ABANTE LIFE SCIENCES FUND B EUR CAP | RVI BIOTECNOLOGÍA | 10,568000 | 09/07/2026 | 16,23% | 48,03% | ** |
| JPM THEMATICS-GENETIC THERAPIES D (ACC) USD | RVI BIOTECNOLOGÍA | 74,619423 | 10/07/2026 | 16,16% | 16,29% | ** |
| DWS ESG BIOTECH FC | RVI BIOTECNOLOGÍA | 192,850000 | 10/07/2026 | 15,33% | 58,57% | *** |
| DWS ESG BIOTECH TFC | RVI BIOTECNOLOGÍA | 224,880000 | 10/07/2026 | 15,25% | 57,81% | *** |
| DWS ESG BIOTECH LC | RVI BIOTECNOLOGÍA | 359,880000 | 10/07/2026 | 14,88% | 55,03% | *** |
| ISHARES AGEING POPULATION UCITS ETF USD (ACC) | RVI BIOTECNOLOGÍA | 9,258443 | 10/07/2026 | 14,11% | 52,13% | ** |
| JPM THEMATICS-GENETIC THERAPIES I2 (ACC) EUR (HEDGED) | RVI BIOTECNOLOGÍA | 114,680000 | 10/07/2026 | 13,78% | 22,06% | ** |
| JPM THEMATICS-GENETIC THERAPIES C2 (ACC) EUR (HEDGED) | RVI BIOTECNOLOGÍA | 121,090000 | 10/07/2026 | 13,76% | 21,92% | ** |
| JPM THEMATICS-GENETIC THERAPIES C2 (DIST) EUR (HEDGED) | RVI BIOTECNOLOGÍA | 119,800000 | 10/07/2026 | 13,76% | 20,80% | ** |
| JPM THEMATICS-GENETIC THERAPIES I (ACC) EUR (HEDGED) | RVI BIOTECNOLOGÍA | 80,620000 | 10/07/2026 | 13,73% | 21,73% | ** |
| JPM THEMATICS-GENETIC THERAPIES C (ACC) EUR (HEDGED) | RVI BIOTECNOLOGÍA | 98,330000 | 10/07/2026 | 13,68% | 21,58% | ** |
| JPM THEMATICS-GENETIC THERAPIES C2 (ACC) CHF (HEDGED) | RVI BIOTECNOLOGÍA | 120,448878 | 10/07/2026 | 13,65% | 21,09% | ** |
